FindTrial
Sign In

The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record when the results are published, which will

3 trials

Sponsors

Novartis (Switzerland), Gedeon Richter Plc, Newcastle upon Tyne Hospitals NHS Foundation Trust

Conditions

The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record when the results are published, which will be within 30 months after the trial has ended. Not SpecifiedThe Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record when the results are published, which will be within 30 months after the trial has ended. Other

Phase 1

Phase I trial, Quotient code: QSC205601
Active, not recruitingISRCTN10521680
Novartis (Switzerland)The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record when the results are published, which will be within 30 months after the trial has ended. Other
Start: 2022-02-02Target: 116Updated: 2026-03-02
Phase 1 trial, HMR code: 21-004
RecruitingISRCTN12926361
Gedeon Richter PlcThe Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record when the results are published, which will be within 30 months after the trial has ended. Not Specified
Start: 2021-08-09Target: 104Updated: 2022-04-04

Phase 2

Phase II study. The Newcastle upon Tyne Hospitals NHS Foundation Trust code: 09422
RecruitingISRCTN98936300
Newcastle upon Tyne Hospitals NHS Foundation TrustThe Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record when the results are published, which will be within 30 months after the trial has ended. Not Specified
Start: 2022-06-01Target: 25Updated: 2022-05-16